Per O Karlsson

24PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersForensic epidemiologyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 02, 2026
Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study.

|Aug 04, 2026
Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

|Jul 30, 2026
Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.

|Apr 16, 2025
Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden.

Anna-Karin Tzikas, Erik Holmberg, Toshima Z Parris

|Feb 05, 2025
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Rebecca J G Drake, Amalia H Landén, Erik Holmberg

|Oct 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis.

Per Karlsson, Anthony Fyles, S Laura Chang

Pageof 4

Frequent Collaborators

12 joint publications

Erik Holmberg

7 joint publications

Martin Sjöström

6 joint publications

Axel Stenmark Tullberg

5 joint publications

Corey W Speers